CAI
Caris Life Sciences, Inc.
27.10$
-1.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q3 21 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.5% | – | – | – | – | -15.2% | +227.5% | +3.1% | +14.3% | +3.3% | +5.8% | |
| – | +15.0% | – | – | – | – | -20.6% | +386.7% | +2.5% | +16.8% | +1.6% | +4.3% | |
| – | +21.2% | +158.5% | – | – | – | -51.2% | +2,204.2% | +4.8% | +5.9% | +2.9% | -15.9% | |
| – | +21.2% | +158.5% | – | – | – | -49.5% | +2,057.6% | +4.8% | +5.9% | +2.9% | -3.7% | |
| – | +14.9% | – | – | – | – | -9.1% | -36.5% | -47.5% | +320.0% | -19.3% | +29.1% | |
| – | – | – | – | – | – | -7.6% | +11.1% | +21.4% | +29.0% | +19.9% | +62.3% | |
| – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +12.1% | -99.2% | – | – | – | +365.7% | -82.6% | +0.8% | +8.3% | +3.7% | +12.1% | |
| – | -27.5% | – | – | – | – | -1.7% | -44.5% | -4.6% | +47.8% | +13.2% | +33.0% | |
| – | +38.9% | – | – | – | – | -0.1% | -88.8% | -10.5% | -97.4% | +3,455.6% | +8.9% | |
| – | -21.6% | – | – | – | – | -12.8% | +18.6% | +0.9% | +35.2% | +78.0% | +23.2% | |
| – | – | – | – | – | – | – | +18.0% | +0.7% | +0.6% | +0.8% | +3.0% | |
| – | +5.9% | -102.5% | – | – | – | – | – | +5.6% | +20.7% | +2.8% | -0.3% | |
| – | +7.8% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +1,353.4% | +0.0% | +10.3% | +0.0% | -9.4% | +8.3% | +7.7% | -2.5% | -2.5% | +0.1% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.